Alana Harris Dent

Array ( [id] => 6493358 [patent_doc_number] => 20100009861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'BREAST CANCER PROGNOSTICS' [patent_app_type] => utility [patent_app_number] => 11/923888 [patent_app_country] => US [patent_app_date] => 2007-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7777 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20100009861.pdf [firstpage_image] =>[orig_patent_app_number] => 11923888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4845873 [patent_doc_number] => 20080182281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'Antibody directed against gastrin-releasing peptide precursor and use thereof' [patent_app_type] => utility [patent_app_number] => 11/974820 [patent_app_country] => US [patent_app_date] => 2007-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8851 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20080182281.pdf [firstpage_image] =>[orig_patent_app_number] => 11974820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 579153 [patent_doc_number] => 07456268 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-25 [patent_title] => 'Materials and methods for inhibiting Wip1' [patent_app_type] => utility [patent_app_number] => 11/868794 [patent_app_country] => US [patent_app_date] => 2007-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6557 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/456/07456268.pdf [firstpage_image] =>[orig_patent_app_number] => 11868794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4812827 [patent_doc_number] => 20080193458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => '125P5C8: TISSUE SPECIFIC PROTEIN HIGHLY EXPRESSED IN VARIOUS CANCERS' [patent_app_type] => utility [patent_app_number] => 11/857405 [patent_app_country] => US [patent_app_date] => 2007-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 40434 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20080193458.pdf [firstpage_image] =>[orig_patent_app_number] => 11857405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6289822 [patent_doc_number] => 20100158894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'PREVENTIVE OR REMEDY FOR ER-NEGATIVE AND HER2-NEGATIVE BREAST CANCER AND METHOD OF SCREENING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/441328 [patent_app_country] => US [patent_app_date] => 2007-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13156 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158894.pdf [firstpage_image] =>[orig_patent_app_number] => 12441328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007039 [patent_doc_number] => 20110059070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'Combination therapy for tumoral desease treatment' [patent_app_type] => utility [patent_app_number] => 12/310790 [patent_app_country] => US [patent_app_date] => 2007-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 17834 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059070.pdf [firstpage_image] =>[orig_patent_app_number] => 12310790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4965250 [patent_doc_number] => 20080108070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'METHODS, COMPOSITIONS, AND KITS FOR THE DETECTION AND MONITORING OF COLON CANCER' [patent_app_type] => utility [patent_app_number] => 11/851267 [patent_app_country] => US [patent_app_date] => 2007-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27841 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20080108070.pdf [firstpage_image] =>[orig_patent_app_number] => 11851267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5452197 [patent_doc_number] => 20090068234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Methods and compositions for the treatment and prevention of cancer' [patent_app_type] => utility [patent_app_number] => 11/899165 [patent_app_country] => US [patent_app_date] => 2007-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 14194 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068234.pdf [firstpage_image] =>[orig_patent_app_number] => 11899165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8555403 [patent_doc_number] => 08329875 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-11 [patent_title] => 'Antibodies to an epitope of AGR2, assays and hybridomas' [patent_app_type] => utility [patent_app_number] => 12/310599 [patent_app_country] => US [patent_app_date] => 2007-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 11869 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12310599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5348811 [patent_doc_number] => 20090004172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'SERVICE FOR EFFECTING LOCALIZED, NON-SYSTEMIC AND SYSTEMIC, IMMUNOGENIC TREATMENT OF CANCER USING ERP57 TRANSLOCATION' [patent_app_type] => utility [patent_app_number] => 11/845068 [patent_app_country] => US [patent_app_date] => 2007-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 13390 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20090004172.pdf [firstpage_image] =>[orig_patent_app_number] => 11845068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5446933 [patent_doc_number] => 20090048159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'KIT FOR TREATING A HEALTH CONDITION BY INDUCING TRANSLOCATION OF A CALRETICULIN PROTEIN TO A CELLULAR MEMBRANE' [patent_app_type] => utility [patent_app_number] => 11/845064 [patent_app_country] => US [patent_app_date] => 2007-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 13399 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20090048159.pdf [firstpage_image] =>[orig_patent_app_number] => 11845064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4676821 [patent_doc_number] => 20080214452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'METHOD FOR EFFECTING LOCALIZED, NON-SYSTEMIC AND SYSTEMIC, IMMUNOGENIC TREATMENT OF CANCER USING CRT TRANSLOCATION' [patent_app_type] => utility [patent_app_number] => 11/845060 [patent_app_country] => US [patent_app_date] => 2007-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 13398 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20080214452.pdf [firstpage_image] =>[orig_patent_app_number] => 11845060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5349944 [patent_doc_number] => 20090005305 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'SERVICE FOR EFFECTING LOCALIZED, NON-SYSTEMIC AND SYSTEMIC, IMMUNOGENIC TREATMENT OF CANCER USING CRT TRANSLOCATION' [patent_app_type] => utility [patent_app_number] => 11/845067 [patent_app_country] => US [patent_app_date] => 2007-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 13350 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20090005305.pdf [firstpage_image] =>[orig_patent_app_number] => 11845067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5348817 [patent_doc_number] => 20090004178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'PHARMACEUTICAL COMPOUND FOR BLOCKING THE CRT OR ERP57 TRANSLOCATION' [patent_app_type] => utility [patent_app_number] => 11/845063 [patent_app_country] => US [patent_app_date] => 2007-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 13398 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20090004178.pdf [firstpage_image] =>[orig_patent_app_number] => 11845063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9427073 [patent_doc_number] => 08703143 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-22 [patent_title] => 'Antibodies of the ED-B domain of fibronectin, their construction and uses' [patent_app_type] => utility [patent_app_number] => 11/842774 [patent_app_country] => US [patent_app_date] => 2007-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13333 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11842774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5304133 [patent_doc_number] => 20090298785 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'Method for Treating Ocular Cancer' [patent_app_type] => utility [patent_app_number] => 12/373308 [patent_app_country] => US [patent_app_date] => 2007-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14857 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298785.pdf [firstpage_image] =>[orig_patent_app_number] => 12373308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5085350 [patent_doc_number] => 20070275401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'USE OF Mx GTPASES IN THE PROGNOSIS AND TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 11/781399 [patent_app_country] => US [patent_app_date] => 2007-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19932 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20070275401.pdf [firstpage_image] =>[orig_patent_app_number] => 11781399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4904497 [patent_doc_number] => 20080113911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Methods of modulating angiogenesis' [patent_app_type] => utility [patent_app_number] => 11/879655 [patent_app_country] => US [patent_app_date] => 2007-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10050 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20080113911.pdf [firstpage_image] =>[orig_patent_app_number] => 11879655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4657085 [patent_doc_number] => 20080025946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'INTERLEUKIN 21 AND TYROSINE KINASE INHIBITOR COMBINATION THERAPY' [patent_app_type] => utility [patent_app_number] => 11/777852 [patent_app_country] => US [patent_app_date] => 2007-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5132 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20080025946.pdf [firstpage_image] =>[orig_patent_app_number] => 11777852 [rel_patent_id] =>[rel_patent_doc_number] =>)